| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |